Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapy
- 30 December 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (8) , 1211-1219
Abstract
To study the prognostic effect of atrial reverse remodelling on outcome of cardiac resynchronization therapy (CRT). Patients receiving a CRT device in the University Medical Centre Groningen were included. Atrial reverse remodelling was defined as a ≥10% reduction in left atrial volume index at 6-month follow-up. Success of CRT was defined as ventricular reverse remodelling with a reduction in left ventricular end-systolic volume of ≥15% at 6-month follow-up. Primary endpoint was all-cause mortality or heart failure hospitalizations. A total of 365 patients (mean age 65.1 ± 11.0 years, 73% men) were included; among them, 221 (61%) were in sinus rhythm and had no prior atrial fibrillation (AF), and 144 patients (39%) had a history of AF. During a mean follow up of 2.0 ± 1.0 years, 49 patients died. Cox regression analysis revealed that patients with no atrial and no ventricular reverse remodelling had the worst outcome (hazard ratio 3.1, 95% confidence interval 1.4-7.1, P = 0.006). Outcome in patients with only atrial reverse remodelling was comparable with outcome in patients with both atrial and ventricular reverse remodelling (hazard ratio 2.0, 95% confidence interval 0.7-5.6, P = 0.21). Patients without atrial and ventricular reverse remodelling have the worst outcome. Patients with only atrial reverse remodelling have improved left ventricular diastolic filling during follow-up and demonstrate a comparable outcome with patients with both atrial and ventricular reverse remodelling. Assessment of atrial reverse remodelling may provide additional prognostic information in determining CRT outcome.Keywords
This publication has 19 references indexed in Scilit:
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)EP Europace, 2013
- Left Atrial Volume Index Predictive of Mortality Independent of Left Ventricular Geometry in a Large Clinical Cohort With Preserved Ejection FractionMayo Clinic Proceedings, 2011
- Left atrial function: physiology, assessment, and clinical implicationsEuropean Heart Journal - Cardiovascular Imaging, 2011
- Usefulness of Left Atrial Volume Index to Predict Heart Failure Hospitalization and Mortality in Ambulatory Patients With Coronary Heart Disease and Comparison to Left Ventricular Ejection Fraction (from the Heart and Soul Study)The American Journal of Cardiology, 2008
- Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapyHeart Rhythm, 2008
- Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythmHeart, 2005
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Cardiac Resynchronization Therapy for Heart FailureCirculation, 2003
- Electrical, contractile and structural remodeling during atrial fibrillationCardiovascular Research, 2002
- A clinical appraisal of left atrial functionEuropean Heart Journal, 2001